+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Toxoid"

From
U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

U.S. Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • December 2024
  • 90 Pages
  • United States
From
From
From
UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

UK Vaccines Market: Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • November 2024
  • 150 Pages
  • United Kingdom
From
From
From
Loading Indicator

Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis. Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers. The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more